J Colloid Interface Sci 2005,283(2):358–365 PubMedCrossRef 42 Be

J Colloid Interface Sci 2005,283(2):358–365.PubMedCrossRef 42. Bessalle R, Kapitkovsky A, Gorea A, Shalit I, Fridkin M: All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 1990,274(1–2):151–155.PubMedCrossRef 43. Suresh K, Mayilraj S, Chakrabarti T: Effluviibacter roseus gen. nov. sp. nov., isolated from muddy water, belonging to the family “ Flexibacteraceae ”. Int J Syst Evol Microbiol 2006,56(7):1703–1707.PubMedCrossRef 44. Tamura C188-9 ic50 K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood,

evolutionary distance and maximum parsimony 17DMAG concentration methods. Mol Biol Evol 2011,28(10):2731–2739.PubMedCrossRef 45. Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41:95–98. 46. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980,16(2):111–120.PubMedCrossRef 47. Vater J, Kablitz B, Wilde C, Franke P, Mehta N, Cameotra SS: Matrix-assisted laser desorbtion ionization-time of flight

mass selleckchem spectrometry of lipopeptide biosurfactants in whole cells and culture filtrates of Bacillus subtilis C-1 isolated from petroleum sludge. Appl Environ Microbiol 2002,68(12):6210–6219.PubMedCrossRef 48. Singh PK, Chittpurna A, Sharma V, Patil PB, Suresh K: Identification, purification and characterization of laterosporulin,

a novel bacteriocin produced by Brevibacillus sp. Strain GI-9. PLoS ONE 2012,7(3):e31498.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions SMM and SS isolated the strains and performed experiments involving identification and characterization NADPH-cytochrome-c2 reductase of strains and lipopeptides, antimicrobial activity assay, analysed the data and wrote the paper. AKP performed the phylogenetic analysis of the strains. AK participated in 16S rRNA gene sequencing and phenotypic characterization of isolates. SK participated in the design, coordination of experiments, analysis of the data and writing the manuscript. All authors read the final manuscript and approved the same.”
“Background Acinetobacter baumannii is a Gram-negative coccobacillus frequently associated with nosocomial infections worldwide [1, 2]. It is an opportunistic pathogen with a wide spectrum of clinical manifestations, including pneumonia, meningitis, and blood stream, urinary tract, and wound infections [3, 4]. A. baumannii has developed resistance to broad-spectrum antibiotics and has thus become problematic in intensive care units (ICUs) [5]. In Taiwan, the first multidrug-resistant A. baumannii (MDRAB) strain was identified in 1998 [6].

Comments are closed.